 <p><b>Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2021 or the DISARM Act of </b><b>2021</b></p> <p>This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.</p>